Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology (Industry)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
59 USD | -5.00% | -9.27% | -29.31% |
May. 09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
May. 08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.31% | 6.51B | |
+5.06% | 109B | |
+11.15% | 105B | |
-0.38% | 22.25B | |
-12.12% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.03% | 16.85B | |
+3.32% | 13.76B | |
+35.95% | 12.46B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics, Incorporated(NasdaqGS: CYTK) added to S&P 400 - Biotechnology